ClinicalTrials.Veeva

Menu

SIB-Norwegian Version, Validation and Reliability Study

S

Sykehuset Innlandet HF

Status

Completed

Conditions

Dementia
Diagnostic Tests, Routine

Treatments

Behavioral: Diagnostic Screening

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).

Full description

The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

Enrollment

59 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Dementia, mild to severe.
  • Nursing Home resident

Exclusion criteria

  • No ability to write or read.
  • Physical handicapped, unable to use hands.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems